{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "NIQ",
  "name": "NIQ Global Intelligence plc",
  "url": "https://orbyd.app/dossiers/NIQ/",
  "json_url": "https://orbyd.app/dossiers/NIQ.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "The IPO re-rate leg already failed — price sits 36.7% under the $18.45 52-week high. What is left is a margin/deleveraging story: Q1 adjusted EBITDA margin 21.0% against a 23.5–23.8% FY26 guide, funded by $70–80M of restructuring savings. The 2026-08-10 after-close Q2 print tests the back-half ramp; the AI/retail-media PR cadence still carries no disclosed revenue.",
  "invalidation_trigger": "A weekly close below $10.50 erases the three-month recovery leg and returns the name to the value-trap frame; secondarily, a 2026-08-10 Q2 print that trims the FY26 5.0–5.3% OCC growth or 23.5–23.8% adjusted EBITDA margin guidance.",
  "catalyst_date": "2026-08-10",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "ai-enterprise-software"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Reports on a calendar year; Q2 2026 covers the quarter ended June 30, 2026, released after market close 2026-08-10.",
    "Reported revenue growth runs well above organic constant-currency growth (11.1% vs 5.1% in Q1 2026) — headline growth overstates the underlying rate.",
    "The equity is valued on adjusted EBITDA and adjusted EPS; GAAP remains a net loss ($90.1M in Q1 2026) after post-take-private interest expense.",
    "Advent-backed since the 2021 take-private and listed only since July 2025 — sponsor ownership remains the standing supply question on any block or secondary.",
    "Partnership announcements (Unlimitail, Ogury, Lula, Circle K) have carried no disclosed contract value; treat them as unquantified until a filing or call attributes revenue."
  ],
  "body_markdown": "## Current Thesis\nThe leg on offer has changed since this name was first written up. The IPO re-rate — buy the Advent-backed measurement franchise near its July 2025 debut and wait for the multiple to normalise — has already failed on price: the last completed close is $11.68 (2026-08-07), 36.7% under the 52-week high of $18.45 and far below the mid-2025 listing reference. What remains is narrower and more arithmetic. Q1 2026 (released 2026-05-14) put adjusted EBITDA margin at 21.0% against a full-year guide of 23.5–23.8%, with $70–80M of annualized restructuring savings named as the funding source and net leverage stated below 3.0x. Organic constant-currency growth was 5.1%. That combination — a mid-single-digit organic top line, a back-half margin step-up and levered free cash flow guided to $235–250M — is a deleveraging story dressed in AI vocabulary. The 2026-08-10 after-close print is where the back-half ramp is either underwritten or exposed. Nothing in the intervening news flow (Circle K extension 2026-07-22, gfknewron Smart Insights 2026-07-24, five-market inflation tracker 2026-08-06) has attached a dollar figure to the AI positioning.\n\n## Bull Case\n- **Operating leverage is showing up in the numbers, not just the deck.** Q1 2026 adjusted EBITDA of $224.8M grew 19.1% YoY on 5.1% organic constant-currency revenue growth, with margin up 150bp to 21.0% (Q1 release, 2026-05-14). EBITDA compounding at roughly four times the organic revenue rate is the entire equity case in one line.\n- **The full-year bar was reaffirmed, not raised.** FY26 guidance stands at 5.0–5.3% OCC growth, 23.5–23.8% adjusted EBITDA margin, $235–250M levered free cash flow and $0.95–0.99 adjusted EPS. A Q2 that simply holds the band on 2026-08-10 keeps the H2 ramp credible.\n- **Balance sheet is not the emergency the post-LBO framing implies.** Net leverage was stated below 3.0x at Q1 alongside a $235M+ levered FCF guide. Debt paydown of that order against a depressed equity base does the re-rating work without requiring growth to accelerate.\n- **Americas is carrying.** Q1 Americas OCC growth of 9.3% ran well ahead of the 5.1% group rate — the geographic mix argument is that the largest retail-media market is where the platform sells first.\n- **One contract with a name on it.** The Circle K multi-year extension (2026-07-22) is a renewal tied to merchandising and pricing decisions rather than another data-sharing memorandum, which is a different class of evidence than the Unlimitail/Ogury/Lula run.\n- **Sell-side panels sit above spot.** stockanalysis.com's panel showed an average target of $14.62 with a $24.00 high as of 2026-08-09, against an $11.68 close.\n\n## Bear Case\n- **The margin guide loads everything into the back half.** Q1 landed at 21.0% against a 23.5–23.8% full-year band. After 2026-08-10 there are two quarters left to deliver a step-up of that size, and Q2 is the first observable on whether it is happening.\n- **GAAP has not crossed over.** Q1 net loss was $90.1M, an improvement of $29.7M YoY but still a loss. The equity is valued off adjusted EBITDA and adjusted EPS; interest expense on the post-take-private capital structure sits between the two.\n- **Six points of the headline growth is not organic.** Reported Q1 revenue rose 11.1% to $1,072.7M while OCC grew 5.1%. Currency and portfolio effects are doing most of that work, and a dollar that stops weakening removes the flattering optics from the reported line.\n- **The AI narrative has produced no attributable revenue in eight weeks of headlines.** Unlimitail (2026-06-16), Ogury (2026-06-18), Lula Commerce (2026-07-07), Circle K (2026-07-22), gfknewron Smart Insights (2026-07-24), inflation tracker (2026-08-06). Six-plus company-issued releases, zero disclosed incremental contract value.\n- **Consumer deflation cuts the client budget base.** NIQ's own tracker (2026-08-06) put France at -0.4%. FMCG value growth is the variable manufacturer and retailer research budgets index to; falling nominal grocery inflation is a headwind to the panel business's pricing power.\n- **The chart has not confirmed anything.** Down 36.7% from the 52-week high with the entire high-teens region overhead, the market has been pricing the value-trap read for four quarters, and a 5% organic grower does not obviously break that.\n\n## Setup & Price Structure\nLife-cycle label: **MATURING**. The dating: the story is fully known (public since July 2025, covered by a double-digit analyst panel), it still functions as a fundamental narrative — 2026-05-14 delivered a beat and a reaffirmed guide — but the attention flow is supply-side. The 2026-07-22, 2026-07-24 and 2026-08-06 headlines are company-issued releases carried by wire aggregators, not fresh third-party initiation. Participation is not visibly expanding.\n\nPrice basis (pipeline adjusted daily bars, as of 2026-08-07): last close $11.68, 52-week high $18.45, distance from high -36.7%, three-month return +9.0%, RSI(14) 64.2. The name walks into a scheduled binary at the upper end of a three-month recovery with momentum elevated. The high-teens shelf that framed the earlier read is well above spot and functions as overhead supply rather than as a base to defend.\n\nCrowding and positioning observables, stated as observables:\n- Earnings one session away — 2026-08-10 after market close, call 5:00 p.m. ET, announced 2026-07-09.\n- RSI(14) at 64.2 into that print, with +9.0% already banked over three months.\n- Target dispersion wider than the share price: stockanalysis.com showed a $14.62 average with a $10.50 low and $24.00 high (2026-08-09), while Investing.com showed $20.74 across 18 analysts on the same date. Aggregator panels disagreeing by roughly the value of the stock is a sign the underwriting range is unresolved.\n- The filings feed shows no insider transactions in the trailing 30 days through 2026-08-07 — no Form 4 selling into the recovery, and no registered secondary from the sponsor.\n- Consensus into the print, per the Zacks preview syndicated 2026-08-03: approximately $0.20 adjusted EPS on roughly $1.11B of revenue, against $1,072.7M reported in Q1.\n\n## Catalyst Calendar (next 30 days)\n- **2026-08-10 (confirmed)** — Q2 2026 results, after market close; conference call 5:00 p.m. ET. Announced by the company 2026-07-09.\n- **~2026-08-11 (est.)** — Q2 Form 10-Q. Where net leverage against the sub-3.0x marker, interest expense and segment-level OCC become checkable rather than narrated.\n- **~2026-09-03 (est.)** — next monthly inflation-tracker release across the five launch markets. Low-impact for the equity, but it dates the direction of FMCG nominal value growth.\n- No other dated company event falls inside the window.\n\n## What Would Change Our Mind\nThe structural break would be the recovery leg giving back, which erases the only bullish price evidence the name currently has: a weekly close below $10.50 puts price under the level it started this three-month advance from and returns the read to the value-trap frame that has held since 2025. Separately, the fundamental break arrives on 2026-08-10 if the FY26 bands move — any trim to the 5.0–5.3% OCC guide, to the 23.5–23.8% adjusted EBITDA margin band, or to the $235–250M levered FCF range says the back-half ramp is not funded, and the $70–80M restructuring savings target becomes a promise rather than a bridge.\n\nConditions that would argue the other way, and are equally observable: a Q2 adjusted EBITDA margin printing materially above the 21.0% Q1 level, evidence that the H2 arithmetic is already in motion; net leverage moving decisively below 3.0x in the 10-Q; or the first quantified revenue attribution for the retail-media partnerships on the call. Any one of those turns the PR cadence into a numbered claim. Absent that, the case for a fresh commitment at $11.68 the session before an unhedgeable print is weak, and waiting for the print to resolve costs only the gap.\n\n## Correlation Notes\n- **Currency is a first-order line item, not background.** Q1 reported growth of 11.1% versus 5.1% OCC means dollar direction moves the headline revenue print by several points. A firming dollar compresses the reported-versus-organic gap at exactly the moment the market is checking the growth rate.\n- **The comp set is information services and ad measurement, not AI infrastructure.** NIQ's peers in the measurement rail (Circana, Kantar, Numerator, YouGov, Ipsos) and the ad-verification cohort set the multiple this equity is marked against. The 2026-07-07 chip rout headline shared a tape with NIQ's own Lula announcement that day; inference, not measurement, but the transmission from AI-hardware volatility into a low-beta panel vendor is weak in both directions.\n- **The demand base is FMCG volume and nominal value growth.** With France at -0.4% on NIQ's own 2026-08-06 tracker, European grocery deflation reduces the nominal denominator client research budgets scale to — the read-through runs through packaged-goods manufacturers and grocery retailers rather than through media.\n- **Sponsor-backed 2025-vintage IPOs trade as a cohort.** Supply mechanics for names that listed into 2025 with a controlling private-equity holder tend to move together on any secondary or block-trade news, independent of operating results.",
  "first_seen": "2026-07-12",
  "last_analyzed": "2026-08-09T18:54:14+00:00",
  "last_synthesized": "2026-08-09",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}